[SYMPTOMATIC CHANGES AND PROVOCATION OF SYMPTOMS IN THE MANAGEMENT OF AFFECTIVE PSYCHOSIS WITH DELIRIOGENIC SUBSTANCES PROTECTED BY METHANESULFONIC ACID DIHYDROERGOTAMINE].
D004087:Dihydroergotamine; D004878:Ergotamine; D006213:Hallucinogens; D001523:Mental Disorders; D008698:Mesylates; D010276:Parasympatholytics; D011600:Psychopharmacology; D011618:Psychotic Disorders; D014116:Toxicology
D006213:Hallucinogens; D008698:Mesylates; D010276:Parasympatholytics; C045880:methanesulfonic acid; D004087:Dihydroergotamine; D004878:Ergotamine
ERGOTAMINE; HALLUCINOGENS; PARASYMPATHOLYTICS; PSYCHOPHARMACOLOGY; PSYCHOSES; TOXICOLOGIC REPORT
SYMPTOMWANDEL UND SYMPTOMPROVOKATION BEI BEHANDLUNG AFFEKTIVER PSYCHOSEN MIT DELIROGENEN SUBSTANZEN UNTER DEM SCHUTZ VON METHANSULFONSAUREM DIHYDROERGOTAMIN.